Market Cap 26.06M
Revenue (ttm) 1.66M
Net Income (ttm) -34.35M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,069.28%
Debt to Equity Ratio 0.00
Volume 1,351,424
Avg Vol 5,568,396
Day's Range N/A - N/A
Shares Out 78.51M
Stochastic %K 52%
Beta 2.11
Analysts Sell
Price Target $4.00

Company Profile

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide injectable suspension for the treatment of macular edema associated with uveitis. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which has completed Phase 2 clinical trial to treat wet AMD. The company has a collaboration with bausch...

Industry: Biotechnology
Sector: Healthcare
Phone: 678 270 3631
Fax: 678 270 4033
Address:
900 North Point Parkway, Suite 200, Alpharetta, United States
SQUEAKSBANDIT
SQUEAKSBANDIT Dec. 9 at 8:30 PM
$CLSD maybe too soon, but took some today even though i despise transacting with the pink sheet market maker
0 · Reply
maphere
maphere Dec. 9 at 7:45 PM
$CLSD Well, tomorrow Viral has been added to provide Opening Remarks at 8:45 and his main session was moved to Wednesday, the attached photo shows both of these presentations.
1 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Dec. 9 at 6:47 PM
$CLSD ridiculous .. IMHO zero value. Last 10-K showed ~61M debt: see
1 · Reply
jbal
jbal Dec. 9 at 4:33 PM
$CLSD Statement of assets and liabilities is filed. $3M cash. $3M in Equipment. A gazillion patents and trademarks of unknown value. $306,000 in unsecured liabilities. $241M unused federal tax loss.
1 · Reply
JaumeIII
JaumeIII Dec. 8 at 9:30 PM
$CLSD tripled my position between .40-.80…not a huge amount of money at this point, otherwise nothing has changed with clsd and the scs other than chap 11 to get things resolved.
1 · Reply
jbal
jbal Dec. 8 at 9:14 PM
$CLSD George said in his affadavit that CLSD has no funded debt, secured or otherwise. Specifically: "As of the Petition Date, the Debtor has no funded debt obligations, including secured debt. As such, its cash on hand is unencumbered and may be used to fund the administration of this Chapter 11 Case and Clearside’s ongoing operations without the need for secured creditor consent or third-party financing. The Debtor has no outstanding trade debt." Combine that with the comments made by CLSD last year that the cost of each P3 trial is $50-60M, and the news from last week that FDA has changed it's wAMD approval process to only require one P3 trial instead of 2. One of 2 things is happening now: 1. CLS-AX is considered worthless by all potential aquirers and the value is of CLS-AX in unchanged by this news. or 2. CLS-AX was worth X by one or more aquirers and is now woth X+$50M. The disinterest in the shares hints at #1. I lean toward #2.
1 · Reply
buyandsold
buyandsold Dec. 8 at 9:02 PM
$CLSD we may see a voluntary dismissal with new financing in place
1 · Reply
rando321456
rando321456 Dec. 8 at 3:36 PM
$CLSD So we're on week 3 of a supposedly 8 week process and still have no idea wtf is going on. This is really just part and parcel of the shit show George has setup. I've been watching the market and investing for 20 years and I don't think I've ever seen a greater display of ineptness or mental illness than what we've seen with Clearside's management over the past year.
2 · Reply
maphere
maphere Dec. 8 at 12:17 AM
$CLSD 23rd?
1 · Reply
Arttard
Arttard Dec. 7 at 7:08 AM
$CLSD How long it takes to court decision?
1 · Reply
Latest News on CLSD
No data available.
SQUEAKSBANDIT
SQUEAKSBANDIT Dec. 9 at 8:30 PM
$CLSD maybe too soon, but took some today even though i despise transacting with the pink sheet market maker
0 · Reply
maphere
maphere Dec. 9 at 7:45 PM
$CLSD Well, tomorrow Viral has been added to provide Opening Remarks at 8:45 and his main session was moved to Wednesday, the attached photo shows both of these presentations.
1 · Reply
LudwigVanBeethoven
LudwigVanBeethoven Dec. 9 at 6:47 PM
$CLSD ridiculous .. IMHO zero value. Last 10-K showed ~61M debt: see
1 · Reply
jbal
jbal Dec. 9 at 4:33 PM
$CLSD Statement of assets and liabilities is filed. $3M cash. $3M in Equipment. A gazillion patents and trademarks of unknown value. $306,000 in unsecured liabilities. $241M unused federal tax loss.
1 · Reply
JaumeIII
JaumeIII Dec. 8 at 9:30 PM
$CLSD tripled my position between .40-.80…not a huge amount of money at this point, otherwise nothing has changed with clsd and the scs other than chap 11 to get things resolved.
1 · Reply
jbal
jbal Dec. 8 at 9:14 PM
$CLSD George said in his affadavit that CLSD has no funded debt, secured or otherwise. Specifically: "As of the Petition Date, the Debtor has no funded debt obligations, including secured debt. As such, its cash on hand is unencumbered and may be used to fund the administration of this Chapter 11 Case and Clearside’s ongoing operations without the need for secured creditor consent or third-party financing. The Debtor has no outstanding trade debt." Combine that with the comments made by CLSD last year that the cost of each P3 trial is $50-60M, and the news from last week that FDA has changed it's wAMD approval process to only require one P3 trial instead of 2. One of 2 things is happening now: 1. CLS-AX is considered worthless by all potential aquirers and the value is of CLS-AX in unchanged by this news. or 2. CLS-AX was worth X by one or more aquirers and is now woth X+$50M. The disinterest in the shares hints at #1. I lean toward #2.
1 · Reply
buyandsold
buyandsold Dec. 8 at 9:02 PM
$CLSD we may see a voluntary dismissal with new financing in place
1 · Reply
rando321456
rando321456 Dec. 8 at 3:36 PM
$CLSD So we're on week 3 of a supposedly 8 week process and still have no idea wtf is going on. This is really just part and parcel of the shit show George has setup. I've been watching the market and investing for 20 years and I don't think I've ever seen a greater display of ineptness or mental illness than what we've seen with Clearside's management over the past year.
2 · Reply
maphere
maphere Dec. 8 at 12:17 AM
$CLSD 23rd?
1 · Reply
Arttard
Arttard Dec. 7 at 7:08 AM
$CLSD How long it takes to court decision?
1 · Reply
rando321456
rando321456 Dec. 5 at 2:27 PM
$CLSD Review of milestones, royalty rates, and status: Bausch: 55 million in milestones, 17-20% royalties, approved Arctic/Santen: 20 million in milestones, 10-12% royalties, filed in China(main market) Regenxbio: ~30 million in dev milestones, ~100 milliin in commercial, ~5% royalties, phase 2b/3 Aura: ~20 million in dev milestones, 3-5% royalties, phase 3 Biocryst: ~30 million dev milestones, ~48 million in commercial milestones, 5-7% royalties, phase 1 Total dev milestone floating: ~90 million, total commercial ~215 million. That is against 106.5 million in obligations to the royalty sub. One thing to take into account when valuing this is that the 106.5 million has to be discounted in the same way as the potential cashflows are.
0 · Reply
norbertm
norbertm Dec. 5 at 1:51 PM
Wow that did not age well, the person being berated made 125% in 24 hours. Reminder to self: avoid cockiness at all cost. $CLSD
3 · Reply
buyandsold
buyandsold Dec. 4 at 9:55 PM
$CLSD i am up for a Friday filing! Reviewing all the Dec 3rd dockets you can see how attorneys make bank: endless basic filings that allegedly take hours to produce.
0 · Reply
rando321456
rando321456 Dec. 4 at 5:54 AM
$CLSD A little bit odd the counsel stated they expected the stalking horse last week or early this week.
2 · Reply
maphere
maphere Dec. 4 at 4:15 AM
$CLSD OK sure why not... https://www.linkedin.com/posts/viral-kansara-phd_2025-dry-amd-ga-therapeutics-summit-ugcPost-7402059641465327617-0kRn?utm_source=share&utm_medium=member_android&rcm=ACoAAAXObpMB_ohGxf74o-pkIrOKz0heKnRRmuk
2 · Reply
maphere
maphere Dec. 4 at 4:03 AM
$BCRX $CLSD I wonder whose drug that could be...? https://www.linkedin.com/posts/cureos_clinicaltrials-diabeticmacularedema-ophthalmology-activity-7399944930187632640-UUlA?utm_source=share&utm_medium=member_android&rcm=ACoAAAXObpMB_ohGxf74o-pkIrOKz0heKnRRmuk
1 · Reply
buyandsold
buyandsold Dec. 3 at 7:09 PM
$CLSD shame the volume is too low to get excited. We traded 30x more around 40 cents. But i am not complaining
1 · Reply
Arttard
Arttard Dec. 3 at 7:02 PM
$CLSD 🤔🤔🤔
0 · Reply
Arttard
Arttard Dec. 3 at 6:11 PM
0 · Reply
CYCYTRTR
CYCYTRTR Dec. 3 at 4:34 PM
$CLSD Don't take the Bait. This will be falling soon!!
1 · Reply
TradeWoFear
TradeWoFear Dec. 3 at 7:53 AM
0 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Dec. 2 at 8:45 PM
$CLSD without news I don't believe these prices can be supported and dare I say this may have become a reddit/momentum play good luck be careful and protect your gains
1 · Reply